Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21565979.
- Also identified by DOI 10.1158/0008-5472.CAN-10-2475 and PMC identifier 7425979.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Selective activation of p53 target genes in response to various cellular stresses is a critical step in determining the ability to induce cell-cycle arrest or apoptosis. Here we report the identification of the microRNA miR-22 as a p53 target gene that selectively determines the induction of p53-dependent apoptosis by repressing p21. Combinatorial analyses of the AGO2 immunocomplex and gene expression profiles identified p21 as a direct target of miR-22. Induction of p21 was inhibited by miR-22 after exposure to the genotoxic agent Adriamycin (doxorubicin; Bedford Laboratories), sensitizing cells to p53-dependent apoptosis. Interestingly, the activation of miR-22 depended on the intensity of the stresses that induced cells to undergo apoptosis in the presence of p21 suppression. Our findings define an intrinsic molecular switch that determines p53-dependent cellular fate through post-transcriptional regulation of p21.
Medical subject headings
- Colonic Neoplasms
- Cyclin-Dependent Kinase Inhibitor p21
- Genes, Tumor Suppressor
- MicroRNAs
- Tumor Suppressor Protein p53